Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, Adult, antibodies, apoptosis, Diseases, Non-Biological, Combinations, Therapies, checkpoint inhibitors, Biological Processes, Technology and Procedures, Plasma Cell Disorders, immunotherapy, cytogenetics, Lymphoid Malignancies, Study Population, Clinically relevant, pathways
	Type: Oral
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, Adult, antibodies, apoptosis, Diseases, Non-Biological, Combinations, Therapies, checkpoint inhibitors, Biological Processes, Technology and Procedures, Plasma Cell Disorders, immunotherapy, cytogenetics, Lymphoid Malignancies, Study Population, Clinically relevant, pathways
Saturday, December 5, 2020: 2:00 PM-3:30 PM
	
	
	
	
	   
			
		Moderators:
			
				
				
					
						
						
						
							Prashant Kapoor, MD, Mayo Clinic
						
					
					
				
					
						 and 
						
						
							Nina Shah, MD, University of California San Francisco
						
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			Shah: BMS, Janssen, Bluebird Bio, Sutro Biopharma, Teneobio, Poseida, Nektar: Research Funding; GSK, Amgen, Indapta Therapeutics, Sanofi, BMS, CareDx, Kite, Karyopharm: Consultancy. 
			 
		2:00 PM
	
	
2:15 PM
	
	
2:30 PM
	
	
2:45 PM
	
	
3:00 PM
	
	
3:15 PM
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					
 denotes an abstract that is clinically relevant.
 denotes an abstract that is clinically relevant. denotes that this is a recommended PHD Trainee Session.
 denotes that this is a recommended PHD Trainee Session. denotes that this is a ticketed session.
 denotes that this is a ticketed session.